{"id":62401,"date":"2025-12-23T22:05:58","date_gmt":"2025-12-23T21:05:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\/"},"modified":"2025-12-23T22:05:58","modified_gmt":"2025-12-23T21:05:58","slug":"akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\/","title":{"rendered":"Akumin Announces Agreement that will Solidify Long-Term Financial Foundation to Support Continued Growth and Patient Care"},"content":{"rendered":"
\n

PLANTATION, Fla.–(BUSINESS WIRE)–Akumin Inc. (together with its subsidiaries \u201cAkumin\u201d or the \u201cCompany\u201d) announced today that it entered into an agreement (the \u201cSupport Agreement\u201d) with certain noteholders representing over 95% of outstanding senior secured notes due in 2027 and 2028 (together, the \u201cSenior Secured Notes\u201d), and Stonepeak, a leading alternative investment firm, that will reduce debt, enhance liquidity and extend its debt maturities related to the Senior Secured Notes. Under the agreement (i) the Company will launch an exchange offer to issue new senior secured notes due 2031 (the \u201cNew Notes\u201d) in exchange for outstanding Senior Secured Notes, which will be retired, and (ii) Stonepeak will continue to provide incremental growth capital to the Company.<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe Company anticipates launching the exchange offer to holders of the Senior Secured Notes in January 2026. The New Notes will accrue cash interest at 9.75%, which will step down to 8.75% upon the Company achieving a specified rating threshold.<\/p>\n

\nIn accordance with the Support Agreement, Stonepeak has committed to investing approximately $154.5 million of new money to support the Company\u2019s long-term business growth upon consummation of the transactions. In addition, the Company\u2019s existing revolving credit facility, with approximately $119 million expected to be outstanding at closing, will either be fully converted into preferred equity if at least 99% of the Senior Secured Notes are tendered in the exchange offer, or, if that threshold is not met, will be subordinated to a second-lien position junior to the New Notes.<\/p>\n

\n\u201cThis transaction will enable us to further strengthen our financial foundation as we look to enhance our essential outpatient radiology and oncology services. We are grateful for the continued support of our bondholders and Stonepeak, and believe this transaction underscores the value of our business and the services we provide to health systems, hospitals, physician groups, and patients all across the country,\u201d said Henry Howe, Chief Executive Officer of Akumin.<\/p>\n

\nGraham Brown, member of the Board of Directors of Akumin and Managing Director at Stonepeak, commented, \u201cWe have long held confidence in Akumin and the critical healthcare services it provides, and have been committed to providing growth capital and operational expertise to the business as needed. We look forward to continuing to support the business as it executes on and advances its strategy for future success.\u201d<\/p>\n

\nThe New Notes will not be registered under the Securities Act of 1933, as amended, or any state securities law and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. This press release does not constitute an offer to sell, nor is it a solicitation of an offer to buy, the Senior Secured Notes or New Notes, nor shall there be any sale of Senior Secured Notes or the New Notes in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state or any jurisdiction.<\/p>\n

\nAbout Akumin<\/b><\/p>\n

\nAkumin is a leading U.S. provider of advanced imaging and radiation oncology services, committed to excellence in patient care and expanding access to life-saving diagnostics and treatments. Serving millions annually, Akumin operates one of the nation\u2019s largest networks of fixed-site radiology centers and mobile imaging and oncology solutions, including the innovative Akumin AXIS Expandable Patient Solutions\u2122. Partnering with over 800 hospitals and physician groups, including 23 of the top 30 health systems, Akumin combines clinical expertise, operational excellence, and advanced technology to broaden access, enhance care standards, and meet community needs. Through innovation and collaboration, Akumin is pioneering the future of patient-centered care. For more information, visit www.akumin.com<\/a>.<\/p>\n

\nForward Looking Information<\/b><\/p>\n

\nCertain information in this press release constitutes forward\u2010looking information. In some cases, but not necessarily in all cases, forward\u2010looking information can be identified by the use of forward\u2010looking terminology such as \u201cplans\u201d, \u201ctargets\u201d, \u201cexpects\u201d or \u201cdoes not expect\u201d, \u201cis expected\u201d, \u201cis positioned\u201d, \u201cestimates\u201d, \u201cintends\u201d, \u201cassumes\u201d, \u201canticipates\u201d or \u201cdoes not anticipate\u201d or \u201cbelieves\u201d, or variations of such words and phrases or state that certain actions, events or results \u201cmay\u201d, \u201ccould\u201d, \u201cwould\u201d, \u201cmight\u201d, \u201cwill\u201d or \u201cwill be taken\u201d, \u201coccur\u201d or \u201cbe achieved.\u201d In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward\u2010looking information. Statements containing forward\u2010looking information are not historical facts but instead represent management\u2019s expectations, estimates and projections regarding future events.<\/p>\n

\nForward\u2010looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by Akumin as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward\u2010looking information. Factors that could cause actual results to differ materially from such forward\u2010looking information include, but are not limited to, the Company\u2019s ability to obtain all regulatory approvals and other conditions to the closing of the Transactions. The Company therefore cautions readers against relying on such forward-looking statements. All forward\u2010looking statements attributable to the Company or persons acting on the Company\u2019s behalf are expressly qualified in their entirety by the foregoing cautionary statements. These factors are not intended to represent a complete list of the factors that could affect Akumin; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward\u2010looking statements contained in this press release are made as of the date of this press release, and Akumin expressly disclaims any obligation to update or alter statements containing any forward\u2010looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.<\/p>\n

Contacts<\/b> <\/p>\n

\nAkumin Investor Relations
\n
investorrelations@akumin.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

PLANTATION, Fla.–(BUSINESS WIRE)–Akumin Inc. (together with its subsidiaries \u201cAkumin\u201d or the \u201cCompany\u201d) announced today that it entered into an agreement (the \u201cSupport Agreement\u201d) with certain noteholders representing over 95% of outstanding senior secured notes due in 2027 and 2028 (together, the \u201cSenior Secured Notes\u201d), and Stonepeak, a leading alternative investment firm, that will reduce debt, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62401","6":"format-standard","7":"category-industry"},"yoast_head":"\nAkumin Announces Agreement that will Solidify Long-Term Financial Foundation to Support Continued Growth and Patient Care - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Akumin Announces Agreement that will Solidify Long-Term Financial Foundation to Support Continued Growth and Patient Care - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PLANTATION, Fla.–(BUSINESS WIRE)–Akumin Inc. (together with its subsidiaries \u201cAkumin\u201d or the \u201cCompany\u201d) announced today that it entered into an agreement (the \u201cSupport Agreement\u201d) with certain noteholders representing over 95% of outstanding senior secured notes due in 2027 and 2028 (together, the \u201cSenior Secured Notes\u201d), and Stonepeak, a leading alternative investment firm, that will reduce debt, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-23T21:05:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251223099870\/en\/2497126\/22\/Akumin-Logo-16x9-BlueA-01.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Akumin Announces Agreement that will Solidify Long-Term Financial Foundation to Support Continued Growth and Patient Care\",\"datePublished\":\"2025-12-23T21:05:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\\\/\"},\"wordCount\":985,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251223099870\\\/en\\\/2497126\\\/22\\\/Akumin-Logo-16x9-BlueA-01.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\\\/\",\"name\":\"Akumin Announces Agreement that will Solidify Long-Term Financial Foundation to Support Continued Growth and Patient Care - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251223099870\\\/en\\\/2497126\\\/22\\\/Akumin-Logo-16x9-BlueA-01.jpg\",\"datePublished\":\"2025-12-23T21:05:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251223099870\\\/en\\\/2497126\\\/22\\\/Akumin-Logo-16x9-BlueA-01.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251223099870\\\/en\\\/2497126\\\/22\\\/Akumin-Logo-16x9-BlueA-01.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Akumin Announces Agreement that will Solidify Long-Term Financial Foundation to Support Continued Growth and Patient Care\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Akumin Announces Agreement that will Solidify Long-Term Financial Foundation to Support Continued Growth and Patient Care - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\/","og_locale":"en_US","og_type":"article","og_title":"Akumin Announces Agreement that will Solidify Long-Term Financial Foundation to Support Continued Growth and Patient Care - Pharma Trend","og_description":"PLANTATION, Fla.–(BUSINESS WIRE)–Akumin Inc. (together with its subsidiaries \u201cAkumin\u201d or the \u201cCompany\u201d) announced today that it entered into an agreement (the \u201cSupport Agreement\u201d) with certain noteholders representing over 95% of outstanding senior secured notes due in 2027 and 2028 (together, the \u201cSenior Secured Notes\u201d), and Stonepeak, a leading alternative investment firm, that will reduce debt, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\/","og_site_name":"Pharma Trend","article_published_time":"2025-12-23T21:05:58+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251223099870\/en\/2497126\/22\/Akumin-Logo-16x9-BlueA-01.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Akumin Announces Agreement that will Solidify Long-Term Financial Foundation to Support Continued Growth and Patient Care","datePublished":"2025-12-23T21:05:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\/"},"wordCount":985,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251223099870\/en\/2497126\/22\/Akumin-Logo-16x9-BlueA-01.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\/","url":"https:\/\/pharma-trend.com\/en\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\/","name":"Akumin Announces Agreement that will Solidify Long-Term Financial Foundation to Support Continued Growth and Patient Care - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251223099870\/en\/2497126\/22\/Akumin-Logo-16x9-BlueA-01.jpg","datePublished":"2025-12-23T21:05:58+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251223099870\/en\/2497126\/22\/Akumin-Logo-16x9-BlueA-01.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251223099870\/en\/2497126\/22\/Akumin-Logo-16x9-BlueA-01.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/akumin-announces-agreement-that-will-solidify-long-term-financial-foundation-to-support-continued-growth-and-patient-care\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Akumin Announces Agreement that will Solidify Long-Term Financial Foundation to Support Continued Growth and Patient Care"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62401","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62401"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62401\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62401"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62401"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}